|
gptkb:Attention_deficit_hyperactivity_disorder
|
gptkb:methylphenidate
|
|
gptkb:Attention_Deficit_Hyperactivity_Disorder
|
gptkb:methylphenidate
|
|
gptkb:COPD
|
beta-agonists
|
|
gptkb:COPD
|
gptkb:theophylline
|
|
gptkb:COPD
|
phosphodiesterase-4 inhibitors
|
|
gptkb:Attention_deficit_hyperactivity_disorder
|
guanfacine
|
|
gptkb:Attention_Deficit_Hyperactivity_Disorder
|
amphetamine
|
|
gptkb:Post-Traumatic_Disorder
|
gptkb:SSRIs
|
|
gptkb:essential_tremor
|
propranolol
|
|
gptkb:Attention_deficit_hyperactivity_disorder
|
amphetamine
|
|
gptkb:Attention_Deficit_Hyperactivity_Disorder
|
gptkb:atomoxetine
|
|
gptkb:essential_tremor
|
primidone
|
|
gptkb:Post-Traumatic_Disorder
|
gptkb:SNRIs
|
|
gptkb:Attention_deficit_hyperactivity_disorder
|
gptkb:clonidine
|
|
gptkb:COPD
|
anticholinergics
|
|
gptkb:Attention_deficit_hyperactivity_disorder
|
gptkb:atomoxetine
|